Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTAM:AKZA
ENXTAM:AKZAChemicals

Assessing Akzo Nobel (ENXTAM:AKZA) Valuation After Year End Results Show Lower Sales But Higher Net Income

Akzo Nobel earnings event and why it matters for investors Akzo Nobel (ENXTAM:AKZA) just released its fourth quarter and full year 2025 results, with lower sales but higher net income. This puts the focus squarely on margins, cost control and overall earnings quality for shareholders. See our latest analysis for Akzo Nobel. The earnings release comes after a mixed year for the share price, with a 7 day share price return of 3.3%, a 30 day share price return of 1.04%, and a 1 year total...
OM:CLA B
OM:CLA BFood

Cloetta (OM:CLA B) Valuation Check After Higher Earnings And A Raised Dividend

Why Cloetta’s latest earnings and dividend move matter for shareholders Cloetta (OM:CLA B) just posted fourth quarter and full year 2025 results showing higher net income and earnings per share, while sales were slightly lower, and paired this with an increased annual dividend announcement. See our latest analysis for Cloetta. The recent earnings beat and higher dividend have arrived after a strong run in the share price, with a 90 day share price return of 41.33% and a 1 year total...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Why Enphase Energy (ENPH) Is Up 34.9% After Q4 Earnings, EV Platform Progress And Buybacks

Enphase Energy reported past fourth-quarter 2025 results showing quarterly sales of US$343.32 million and net income of US$38.71 million, alongside full-year 2025 revenue of US$1.47 billion and net income of US$172.13 million, and issued first-quarter 2026 revenue guidance of US$270.0 million to US$300.0 million. The company also highlighted progress on its IQ Bidirectional EV Charging Platform and completed a US$731.34 million share repurchase program covering 8,869,963 shares. Against this...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Texas Instruments Eyes AI Data Center Growth With Silicon Labs Deal

Texas Instruments has entered a definitive agreement to acquire Silicon Labs, aiming to broaden its role in AI-focused data center infrastructure. The transaction is tied to Texas Instruments' push around analog chips and internal changes that highlight data center demand for AI hardware. For investors watching NasdaqGS:TXN, this move adds a fresh layer to the story behind a share price of $218.77 and multi year returns of 35.8% over 3 years and 39.6% over 5 years. The company is already...
TSE:4021
TSE:4021Chemicals

Nissan Chemical (TSE:4021) Q3 Net Margin Decline Tests Steady Earnings Growth Narrative

Nissan Chemical (TSE:4021) has released a detailed scorecard for Q3 2026, reporting revenue of ¥65,341 million and basic EPS of ¥90.67, supported by net income of ¥12,216 million for the quarter. The company’s revenue increased from ¥56,647 million in Q3 2025 to ¥65,341 million in Q3 2026, while EPS moved from ¥81.51 to ¥90.67 over the same period. Investors may weigh these higher headline figures against indications of slightly softer profit margins over the year. See our full analysis for...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Should Zimmer Biomet’s (ZBH) Consistent Revenue Outperformance Shape Investor Expectations For This Earnings Release?

Zimmer Biomet Holdings recently reported that it will release its upcoming earnings results, with analysts expecting revenue of about US$2.22 billion, reflecting year-on-year growth of 9.9% and an improvement from the 4.3% increase recorded in the same quarter a year earlier. An interesting angle is that Zimmer Biomet has missed Wall Street’s revenue estimates only once in the past two years, typically outperforming consensus by an average of 0.7%, which may be influencing how investors...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Momentum And Biosimilar Growth Hopes

Why Teva Pharmaceutical Industries (NYSE:TEVA) is on investors’ radar today Teva Pharmaceutical Industries (NYSE:TEVA) has drawn fresh attention after recent share price moves, with the stock showing mixed short term returns but a stronger gain over the past 3 months. See our latest analysis for Teva Pharmaceutical Industries. While the latest 1 day share price return of 0.63% and 7 day return of 2.96% show some cooling at a recent price of US$34.47, the 90 day share price return of 37.17%...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS) Is Up 8.1% After Mixed 2025 Results And Trillium Deal - Has The Bull Case Changed?

Flowserve Corporation recently reported fourth-quarter and full-year 2025 results showing higher sales but a quarterly net loss, while issuing 2026 guidance calling for modest organic and total sales growth. The company also outlined longer-term margin ambitions and highlighted opportunities in nuclear and power markets, supported by the planned US$490.00 million acquisition of Trillium Flow Technologies’ valves division. We’ll now examine how Flowserve’s improved margin trajectory and 2026...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo Pharmaceuticals (SWX:COPN) Valuation Check After Treasury Share Placement With Small Cap World Fund

Fresh equity placement puts Cosmo Pharmaceuticals in focus Cosmo Pharmaceuticals (SWX:COPN) has drawn attention after completing a private placement of 937,086 treasury shares, equal to 5.3% of its outstanding shares, with participation from Small Cap World Fund of the Capital Group. See our latest analysis for Cosmo Pharmaceuticals. At a share price of CHF117.0, Cosmo Pharmaceuticals has seen a 30 day share price return of 7.93% and a 90 day gain of 80.28%. Its 1 year total shareholder...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

A Look At Expand Energy (EXE) Valuation As Leadership Changes And Headquarters Move Proceed

Expand Energy (EXE) is entering a transition period, with Chairman Michael Wichterich stepping in as Interim President and CEO while the company prepares to shift its headquarters from Oklahoma City to Houston. See our latest analysis for Expand Energy. The recent headquarters move and leadership reshuffle come as the stock trades at US$103.24. The 1 day share price return shows a 6.46% decline and the 90 day share price return shows a 12.98% decline, while the 5 year total shareholder return...
NYSE:CNS
NYSE:CNSCapital Markets

A Look At Cohen & Steers (CNS) Valuation After AUM Growth And Resilient Earnings

Latest AUM update and earnings context Cohen & Steers (CNS) reported preliminary assets under management of US$93.1b as of January 31, 2026, tied to market appreciation and net inflows, alongside ongoing revenue growth and maintained profitability, despite earnings that were slightly below forecast. See our latest analysis for Cohen & Steers. At a share price of US$64.30, Cohen & Steers has seen a 2.54% 1 day share price return and a modest 0.97% 7 day share price return. Its 1 year total...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Is Voyager Technologies (VOYG) Now At An Interesting Price After Recent Share Weakness

If you are wondering whether Voyager Technologies is starting to look like good value or just fairly priced at today’s levels, you are in the right place. The share price closed at US$29.05, with a flat 7 day return, a 7.3% decline over the last 30 days, and a 4.6% gain year to date. This may signal shifting views on both opportunity and risk. Recent attention on Voyager Technologies has centered on its position within the capital goods sector and how its current share price lines up with...
NYSE:OMF
NYSE:OMFConsumer Finance

A Look At OneMain Holdings (OMF) Valuation After In Line Results And 2026 Growth Plans

OneMain Holdings (OMF) is back in focus after reporting fourth quarter and full year 2025 results that met Wall Street revenue expectations, alongside plans to expand in auto finance and credit cards in 2026. See our latest analysis for OneMain Holdings. Despite the latest earnings beat and plans to grow in auto finance and credit cards, OneMain Holdings’ recent 30-day share price return of a 12.39% decline and year-to-date weakness contrast with a 1-year total shareholder return of 18.12%...
OM:NOLA B
OM:NOLA BIndustrials

Assessing Nolato (OM:NOLA B) Valuation After Strong Full Year Results And Higher Dividend

Nolato (OM:NOLA B) has drawn fresh attention after announcing an annual dividend of SEK 1.70 per share, scheduled for payment on May 13, 2026, alongside its stronger full year results. See our latest analysis for Nolato. Despite the stronger full year performance and the dividend announcement, Nolato’s recent momentum has been weak, with a 30 day share price return of 14.71% and a 1 year total shareholder return of 16.68%, while the 3 year total shareholder return of 9.01% signals a more...
NYSE:UHAL
NYSE:UHALTransportation

Is U-Haul Holding (UHAL) Pricing Look Stretched After Prolonged Share Price Declines

If you are wondering whether U-Haul Holding is starting to look appealing at its current share price, this article walks through what that price might really imply about value. The stock recently closed at US$48.81, with returns of 14.7% decline over 7 days, 10.9% decline over 30 days, 3.4% decline year to date, and 31.3% decline over 1 year, which may have changed how some investors view its risk and potential. Recent coverage around U-Haul often focuses on its core role in truck and...
Catalist:42C
Catalist:42CPharmaceuticals

IX Biopharma (Catalist:42C) H1 Loss Of S$2.1 Million Reinforces Profitability Concerns

iX Biopharma (Catalist:42C) has released its H1 2026 numbers, reporting revenue of S$3.2 million and a basic EPS loss of S$0.00226. This continues to draw attention to the company’s path toward profitability. The company’s half yearly revenue moved from S$3.7 million in H1 2025 to S$4.1 million in H2 2025 and then to S$3.2 million in H1 2026. Over the same periods, basic EPS losses were S$0.00717, S$0.00442 and S$0.00226, respectively, leaving investors focused on how much of each sales...
TSE:9434
TSE:9434Wireless Telecom

SoftBank (TSE:9434) Q3 EPS Slowdown Tests Bullish Earnings Growth Narrative

SoftBank (TSE:9434) has just posted its Q3 2026 scorecard, with revenue of about ¥1.79t and basic EPS of ¥2.82, supported by trailing twelve month EPS of ¥11.88 on revenue of roughly ¥6.93t. The company has seen quarterly revenue move from about ¥1.66t in Q1 2026 to ¥1.74t in Q2 and now ¥1.79t in Q3, while quarterly EPS tracked at ¥3.00 in Q1, ¥4.22 in Q2 and ¥2.82 in Q3. This sets the stage for investors to weigh consistency against the latest headline numbers. With net profit margins...
NYSE:EAT
NYSE:EATHospitality

Brinker International (EAT) Valuation Check After Raised 2026 Guidance And Solid Earnings Performance

Brinker International (EAT) is back in focus after raising full year 2026 earnings guidance along with its latest quarterly report, highlighting updated revenue and profitability targets that investors are now weighing against the recent share price move. See our latest analysis for Brinker International. The raised 2026 earnings guidance and solid recent quarter sit against a share price that has climbed 61.81% over 90 days and a very large 3 year total shareholder return of 320.97%. This...
NYSE:TJX
NYSE:TJXSpecialty Retail

Senator Trade Puts TJX Companies (TJX) In Focus For A Fresh Look At Valuation And Growth Potential

Why a senator’s TJX trade is drawing fresh attention Senator John W Hickenlooper’s recent purchase of TJX Companies (TJX) shares has put the off price retailer back on investors’ radar, raising questions about how its fundamentals stack up today. See our latest analysis for TJX Companies. TJX’s latest share price of $156.24 comes after a 4.0% 7 day share price return and a 6.9% 90 day share price return. Its 1 year total shareholder return of 26.6% and 3 year total shareholder return of about...